Common Contracts

CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THE AGREEMENT BECAUSE SUCH INFORMATION (I) IS CONSIDERED NOT MATERIAL TO INVESTORS AND (II) IS INFORMATION THAT THE REGISTRANT, CANOPY GROWTH CORPORATION., TYPICALLY TREATS AS PRIVATE OR CONFIDENTIAL IN THE...

Credit Agreement • July 14th, 2023 • Canopy Growth Corp • Medicinal chemicals & botanical products • New York

• Contract Type
  Credit Agreement
• Filed
  July 14th, 2023
• Company
  Canopy Growth Corp
• Industry
  Medicinal chemicals & botanical products
• Jurisdiction
  New York

CREDIT AGREEMENT, dated as of March 18, 2021 (this “Agreement”), among CANOPY GROWTH CORPORATION, a corporation incorporated under the federal laws of Canada (the “Parent Borrower”), 11065220 Canada Inc., a corporation incorporated under the federal laws of Canada (the “Co-Borrower” and, together with the Parent Borrower, the “Borrowers” and each, a “Borrower”), the LENDERS party hereto from time to time and WILMINGTON TRUST, NATIONAL ASSOCIATION, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) and Collateral Agent (as defined below) for the Secured Parties (as defined below).

Certain identified confidential information contained in this document, marked by brackets, has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

Credit Agreement • October 27th, 2022 • Canopy Growth Corp • Medicinal chemicals & botanical products • New York

• Contract Type
  Credit Agreement
• Filed
  October 27th, 2022
• Company
  Canopy Growth Corp
• Industry
  Medicinal chemicals & botanical products
• Jurisdiction
  New York

CREDIT AGREEMENT, dated as of March 18, 2021 (this “Agreement”), among CANOPY GROWTH CORPORATION, a corporation incorporated under the federal laws of Canada (the “Parent Borrower”), 11065220 Canada Inc., a corporation incorporated under the federal laws of Canada (the “Co-Borrower” and, together with the Parent Borrower, the “Borrowers” and each, a “Borrower”), the LENDERS party hereto from time to time and WILMINGTON TRUST, NATIONAL ASSOCIATION, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) and Collateral Agent (as defined below) for the Secured Parties (as defined below).

CREDIT AGREEMENT Dated as of June 16, 2022 among MALLINCKRODT PLC, as the Parent, MALLINCKRODT INTERNATIONAL FINANCE S.A., as Lux Borrower, MALLINCKRODT CB LLC, as Co-Borrower, THE LENDERS PARTY HERETO, ACQUIOM AGENCY SERVICES LLC and SEAPORT LOAN...

Credit Agreement • June 22nd, 2022 • Mallinckrodt PLC • Pharmaceutical preparations • New York

• Contract Type
  Credit Agreement
• Filed
  June 22nd, 2022
• Company
  Mallinckrodt PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

CREDIT AGREEMENT dated as of June 16, 2022 (this “Agreement”), among MALLINCKRODT PLC, a public limited company incorporated under the laws of Ireland with registered number 522227 (the “Parent”), MALLINCKRODT INTERNATIONAL FINANCE S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg (“Luxembourg”), having its registered office at 124, boulevard de la Pétrusse, L-2330 Luxembourg, and registered with the Luxembourg Trade and Companies Register (R.C.S. Luxembourg) under number B 172.865 (the “Lux Borrower”), Mallinckrodt CB LLC, a Delaware limited liability company (the “Co-Borrower”), the LENDERS party hereto from time to time, ACQUIOM AGENCY SERVICES LLC (“Acquiom”) and SEAPORT LOAN PRODUCTS LLC (“Seaport”) as co-administrative agents (in such capacities, together with their successors and permitted assigns in such capacities, each a “Co-Administrative Agent” and together, the “Administrative Agent”) for the Lenders, an